Beschrijving:

CALGB 40302 TREATMENT AND RESPONSE SUMMARY FORM (SUBSET OF PATIENTS) Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive NCT00390455 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F5BC1727-9755-553F-E034-0003BA3F9857

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F5BC1727-9755-553F-E034-0003BA3F9857
Trefwoorden:
  1. 26-08-12 26-08-12 -
  2. 08-01-15 08-01-15 - Martin Dugas
Geüploaded op:

8 januari 2015

DOI:
Voor een aanvraag inloggen.
Licentie :
Creative Commons BY-NC 3.0 Legacy
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

TREATMENT AND RESPONSE SUMMARY FORM Breast Cancer (NCT00390455)

INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted. For optimal accuracy use black ink.

Header
Are data amended
Lapatinib/placebo
Dose Modification (Change)
Were there any delays in dose administration
Fluvestrant
Laboratory Values
%
1000/uL
mg/dL
mg/dL
Response Assessment
Has the patient achieved a response?
Has the patient been diagnosed with a new progression (during this reporting period not previously reported?)
Progressive disease documentation (Mark one with an X.)

Similar models

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial